Literature DB >> 10288957

Priority setting in public and private health care. A guide through the ideological jungle.

A Williams.   

Abstract

Priority setting means deciding who is to get what at whose expense. In the context of health care, the 'what' is that statement refers to different sorts of health care, and the 'who' to different sorts of people. The 'whose expense' is not so straightforward. It appears to refer to 'who will pay the bill', and in a public health care system this might seem to be the government, though behind the government stands the taxpayer, and that means all of us. Even in a private health care system it is rarely the patient who meets the bill directly, for some or all of it will be met by an insurer, and the costs of any particular treatment episode will be spread over many premium-payers. But in the context of an economic, rather than a financial, analysis the phrase 'at whose expense' has to be interpreted in a different way, based on the notion of opportunity cost, rather than on the notion of expenditure. When so reinterpreted, it means 'who is to go without' health care in order that other shall have it. Giving priority to one group of people means taking it away from another group, though for obvious reasons politicians tend not to dwell on this implication, leaving us to infer, from what is not said, who the 'low priority' groups are. In any honest and open discussion of these issues, however, that implication must be faced squarely, and we must not shrink from identifying who (implicitly) the 'low priority' people are, in any particular system of health care.

Entities:  

Mesh:

Year:  1988        PMID: 10288957     DOI: 10.1016/0167-6296(88)90015-x

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  13 in total

1.  Economic notes: definitions of efficiency.

Authors:  S Palmer; D J Torgerson
Journal:  BMJ       Date:  1999-04-24

2.  Public health and valorization of genome-based technologies: a new model.

Authors:  Jonathan A Lal; Tobias Schulte In den Bäumen; Servaas A Morré; Angela Brand
Journal:  J Transl Med       Date:  2011-12-05       Impact factor: 5.531

3.  The impact of New York City's 1975 fiscal crisis on the tuberculosis, HIV, and homicide syndemic.

Authors:  Nicholas Freudenberg; Marianne Fahs; Sandro Galea; Andrew Greenberg
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

4.  NHS reform: the risks of jumping on the spot again.

Authors:  Alan Maynard
Journal:  J R Soc Med       Date:  2013-05       Impact factor: 5.344

5.  Equity in specialist waiting times by socioeconomic groups: evidence from Spain.

Authors:  Ignacio Abásolo; Miguel A Negrín-Hernández; Jaime Pinilla
Journal:  Eur J Health Econ       Date:  2013-08-02

6.  The individual in mainstream health economics: a case of Persona Non-grata.

Authors:  John B Davis; Robert McMaster
Journal:  Health Care Anal       Date:  2007-04-05

7.  Efficiency in mental health practice and research.

Authors:  Isabel T Lagomasino; Douglas F Zatzick; David A Chambers
Journal:  Gen Hosp Psychiatry       Date:  2010-08-13       Impact factor: 3.238

Review 8.  The agency problem and medical acting: an example of applying economic theory to medical ethics.

Authors:  Andreas Langer; Peter Schröder-Bäck; Alexander Brink; Johannes Eurich
Journal:  Med Health Care Philos       Date:  2008-05-10

9.  Competition in health markets: is something rotten?

Authors:  Livio Garattini; Anna Padula
Journal:  J R Soc Med       Date:  2018-12-03       Impact factor: 5.344

10.  Effectiveness Guidance Document (EGD) for acupuncture research - a consensus document for conducting trials.

Authors:  Claudia M Witt; Mikel Aickin; Trini Baca; Dan Cherkin; Mary N Haan; Richard Hammerschlag; Jason Jishun Hao; George A Kaplan; Lixing Lao; Terri McKay; Beverly Pierce; David Riley; Cheryl Ritenbaugh; Kevin Thorpe; Sean Tunis; Jed Weissberg; Brian M Berman
Journal:  BMC Complement Altern Med       Date:  2012-09-06       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.